Cather Jennifer Clay, Cather John Christian, Abramovits William
Texas Dermatology Associates, 5310 Harvest Hill, Dallas, TX 75230, USA.
J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S133-8. doi: 10.1016/s0190-9622(03)01147-2.
As the pathogenesis of psoriasis is better understood, specific targeted therapies are being developed. In addition to alefacept, etanercept, efaluzimab, and infliximab, discussed in separate articles in this issue, numerous other investigational therapies are currently in clinical trials, some of which will likely be approved in the future. We review the most promising of these therapies and their mechanisms of action.
随着对银屑病发病机制的深入了解，正在研发特定的靶向治疗方法。除了本期单独文章中讨论的阿法赛特、依那西普、依法珠单抗和英夫利昔单抗外，目前还有许多其他研究性治疗方法正在进行临床试验，其中一些可能会在未来获得批准。我们综述了这些最有前景的治疗方法及其作用机制。
